Susan L Slager
Overview
Explore the profile of Susan L Slager including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
285
Citations
9503
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kleinstern G, Robinson D, Rimsza L, Larson M, King R, Nowakowski G, et al.
Cancer Epidemiol Biomarkers Prev
. 2025 Mar;
PMID: 40047811
Background: Diffuse large B-cell lymphoma (DLBCL) is clinically heterogeneous, and gene expression profiling has identified at least two biologically distinct DLBCL subtypes defined by their cell-of-origin (COO): germinal center B-cell...
2.
de Campos C, McCabe C, Bruins L, OBrien D, Brown S, Tschumper R, et al.
Blood Cancer J
. 2025 Feb;
15(1):14.
PMID: 39910036
Despite the considerable effort to characterize the genomic landscape of chronic lymphocytic leukemia (CLL), published data have been almost exclusively derived from patients of European Ancestry (EA), with significant underrepresentation...
3.
Hampel P, Rabe K, Wang Y, Hwang S, Kenderian S, Muchtar E, et al.
Leukemia
. 2024 Dec;
39(2):503-507.
PMID: 39658628
No abstract available.
4.
Giaccherini M, Clay-Gilmour A, Liotti R, Macauda A, Gentiluomo M, Brown E, et al.
Blood Cancer J
. 2024 Nov;
14(1):200.
PMID: 39528488
No abstract available.
5.
Sekar A, Griffin R, Parikh S, Genovese G, Robinson D, Norman A, et al.
Blood Cancer J
. 2024 Nov;
14(1):193.
PMID: 39505849
MBL is a precursor condition to chronic lymphocytic leukemia (CLL), characterized by monoclonal B-cells in blood. Mosaic chromosomal alterations (mCAs) are a form of clonal hematopoiesis that include gains, losses,...
6.
Visram A, Larson D, Norman A, Norman A, Dispenzieri A, Murray D, et al.
Blood
. 2024 Oct;
145(3):325-333.
PMID: 39437710
Monoclonal gammopathy of undetermined significance (MGUS) is an asymptomatic premalignant disorder. The current standard of care is not to screen for MGUS, so it is often incidentally diagnosed in the...
7.
Glimelius I, Kleinstern G, Robinson D, Mansouri L, Rostgaard K, Hjalgrim H, et al.
EJHaem
. 2024 Oct;
5(5):998-1004.
PMID: 39415908
Background: Chronic lymphocytic leukemia (CLL) is a heterogeneous disease. Whereas some patients have an indolent disease, others experience an aggressive course and early death. Our aim was to investigate if...
8.
Koehler A, Rabe K, Crusan D, Call T, Achenbach S, Hampel P, et al.
J Thromb Haemost
. 2024 Sep;
23(1):149-157.
PMID: 39343103
Background: The incidence, risk factors, and outcomes of venous thromboembolism (VTE) in patients with chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis (MBL) are not well described. Objectives: We aimed...
9.
Vallejo B, Ansari A, Parikh S, Achenbach S, Rabe K, Norman A, et al.
J Clin Oncol
. 2024 Sep;
42(35):4153-4162.
PMID: 39231386
Purpose: Chronic lymphocytic leukemia (CLL)-phenotype monoclonal B-cell lymphocytosis (MBL) is a premalignant condition that is roughly 500-fold more common than CLL. It is unknown whether the two-fold increased risk of...
10.
Stokes M, Wenzl K, Huang C, Ortiz M, Hsu C, Maurer M, et al.
Nat Commun
. 2024 Aug;
15(1):6790.
PMID: 39117654
Immunochemotherapy has been the mainstay of treatment for newly diagnosed diffuse large B-cell lymphoma (ndDLBCL) yet is inadequate for many patients. In this work, we perform unsupervised clustering on transcriptomic...